Nivalis Therapeutics to Present at Two Upcoming Investor Conferences

BOULDER, Colo., Sept. 4, 2015 (GLOBE NEWSWIRE) -- Nivalis Therapeutics, Inc. (NASDAQ:NVLS), a clinical stage pharmaceutical company focused on treating people with cystic fibrosis, today announced that Chief Executive Officer Jon Congleton will present a corporate overview at the Rodman and Renshaw 17th Annual Global Investment Conference and the Baird 2015 Healthcare Conference.

Details of the two presentations are as follows:

Rodman and Renshaw 17th Annual Global Investment Conference
Date: Wednesday, September 9th
Location: The St. Regis Hotel, New York
Presentation Time: 10:50 AM EDT

Baird 2015 Healthcare Conference
Date: Thursday, September 10th
Location: The New York Palace, New York
Presentation Time: 8:30 AM EDT

Individuals may access a live webcast of the conference presentations on the Nivalis website at under "IR Calendar" in the "News / Events" section. A replay of the webcast will be available on this site for 90 days following the live event.

About Nivalis Therapeutics, Inc.

Nivalis Therapeutics, Inc. ( is a clinical stage pharmaceutical company committed to the discovery, development and commercialization of therapeutics for people with cystic fibrosis. In addition to developing innovative solutions intended to extend and improve the lives of people with cystic fibrosis, Nivalis plans to utilize its proprietary S-nitrosoglutathione reductase (GSNOR) inhibitor portfolio to develop therapeutics for other diseases.

CONTACT: Investor Relations Contact John Graziano 1-646-378-2942 Media Contact Lindsay Rocco 1-862-596-1304 lrocco@elixirhealthpr.comSource:Nivalis Therapeutics